Balyasny Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.59M Buy
1,507,782
+1,297,841
+618% +$2.23M ﹤0.01% 1083
2025
Q1
$699K Sell
209,941
-2,609,858
-93% -$8.69M ﹤0.01% 1471
2024
Q4
$20.9M Sell
2,819,799
-1,652,777
-37% -$12.2M 0.03% 488
2024
Q3
$42M Sell
4,472,576
-67,984
-1% -$638K 0.07% 266
2024
Q2
$36.4M Buy
4,540,560
+3,339,696
+278% +$26.8M 0.06% 300
2024
Q1
$17.8M Sell
1,200,864
-2,725,295
-69% -$40.4M 0.03% 501
2023
Q4
$31.9M Sell
3,926,159
-550,677
-12% -$4.48M 0.06% 314
2023
Q3
$20.4M Buy
4,476,836
+2,937,029
+191% +$13.4M 0.04% 428
2023
Q2
$10.8M Sell
1,539,807
-1,195,779
-44% -$8.42M 0.02% 571
2023
Q1
$16.7M Buy
2,735,586
+2,731,832
+72,771% +$16.7M 0.04% 467
2022
Q4
$24K Sell
3,754
-1,739,778
-100% -$11.1M ﹤0.01% 2019
2022
Q3
$16.7M Buy
1,743,532
+233,743
+15% +$2.24M 0.05% 402
2022
Q2
$16.7M Buy
1,509,789
+415,765
+38% +$4.59M 0.05% 395
2022
Q1
$18.2M Buy
1,094,024
+297,189
+37% +$4.95M 0.06% 352
2021
Q4
$15.2M Sell
796,835
-166,625
-17% -$3.18M 0.05% 426
2021
Q3
$23.8M Buy
963,460
+354,336
+58% +$8.74M 0.1% 254
2021
Q2
$15.8M Buy
609,124
+441,812
+264% +$11.5M 0.08% 327
2021
Q1
$5.3M Buy
+167,312
New +$5.3M 0.03% 561
2020
Q4
Sell
-437,864
Closed -$14.4M 1324
2020
Q3
$14.4M Buy
+437,864
New +$14.4M 0.11% 240
2020
Q2
Sell
-355,779
Closed -$10.7M 1137
2020
Q1
$10.7M Buy
+355,779
New +$10.7M 0.13% 201
2019
Q2
Sell
-38,011
Closed -$361K 1435
2019
Q1
$361K Sell
38,011
-13,104
-26% -$124K ﹤0.01% 1161
2018
Q4
$452K Sell
51,115
-93,172
-65% -$824K ﹤0.01% 1022
2018
Q3
$1.62M Buy
144,287
+109,210
+311% +$1.23M 0.01% 846
2018
Q2
$449K Buy
+35,077
New +$449K ﹤0.01% 1201